Archives

by in
Entry Author Date Location
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking 09/01/09 Boston
Genzyme Asks FDA To Approve Drug for Acute Myeloid Leukemia 11/24/08 Boston
Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech 05/23/08 Boston
The Xconomy Half-Dozen-Stories-of-the-Half-Year Awards 12/27/07 Boston
Genzyme Comes Back to Win Bioenvision Vote—Disputed Merger to Go Forward 10/22/07 Boston
Hologic Faces Lawsuit, OLPC Chooses a Distributor, Point Therapeutics Agrees to a Reverse Merger, and More 10/15/07 Boston
Genzyme and Bioenvision Win Court’s Permission to Reopen Voting on Troubled Merger Agreement 10/10/07 Boston
Still No Conclusion to Genzyme-Bioenvision Saga 10/05/07 Boston
Genzyme Takeover Bid for Bioenvision Still Alive as Special Session Adjourns For the Day 10/04/07 Boston
Genzyme to Bioenvision Board: Acquisition Offer Price Will Not be Raised 09/27/07 Boston
Saying Bioenvision is Poised for a “Home Run,” Investor Files New Challenge to Genzyme Takeover Bid 09/12/07 Boston
Another Voice Heard in the Genzyme-Bioenvision Takeover Debate: Elliot Associates is “Extremely Dissatisfied” 09/06/07 Boston
Former Bioenvision Exec Sues for $108 Million; Genzyme Biding Its Time on Takeover 08/23/07 Boston
Special Vote Called for on Genzyme’s Takeover Bid for Bioenvision: Is a Deal in the Works? 08/20/07 Boston
Good News for Genzyme, Bad News for Boston Scientific, and all the Other News We Didn’t Get to This Week 08/03/07 Boston
Bioenvision Update: Merger Foe Stops Blogging After Genzyme Subpoena; Board Battle Continues 07/25/07 Boston
Christopher Wood: Step Up, Then Step Down 07/18/07 Boston
Genzyme Fires Back, Says It Will Block Addition of New Bioenvision Board Members 07/17/07 Boston
Shake Up at Bioenvision: Two Board Members Resign 07/16/07 Boston
Who’s Cashing in on Bioenvision Sale to Genzyme: The List 07/13/07 Boston
Bioenvison Shareholder Calls for New Board, Revocation of Genzyme’s License 07/11/07 Boston
No New Shares Tendered in Bioenvision Deal; Genzyme Still Hopes for Merger 07/10/07 Boston
Genzyme’s Second Try for Bioenvision Will Also Fail, Sources Predict; Institutional Investors Seek Higher Price 07/09/07 Boston
Genzyme Takeover of Bioenvision Falls Short; Company Tries New Tack 07/02/07 Boston
Genzyme Takeover Deal Will Fail, Predicts Bioenvision Shareholder 06/29/07 Boston
A Deal Too True to be Good? Shareholder Uprising Aims to Disrupt Genzyme’s Takeover Plans 06/07/07 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.